Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort

BACKGROUND: The best management for rare epidermal growth factor receptor (EGFR) mutations in advanced non-small cell lung carcinoma (NSCLC) remains uncertain. The literature indicates that response to usual treatment could differ in certain subgroups such as exon 20 insertion/duplication (E20ID), o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tankere, Pierre, Boidot, Romain, Bonniaud, Philippe, Zouak, Ayoube, Foucher, Pascal, Milliere, Alice, Bertaut, Aurélie, Favier, Laure, Lagrange, Aurélie, Ghiringhelli, François, Kaderbhai, Courèche Guillaume, Fraisse, Cléa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264085/
https://www.ncbi.nlm.nih.gov/pubmed/35813741
http://dx.doi.org/10.21037/jtd-21-1924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264085/
https://www.ncbi.nlm.nih.gov/pubmed/35813741
http://dx.doi.org/10.21037/jtd-21-1924

Ejemplares similares